Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

FDA advisory committee deems ACEL-IMUNE safe and effective for use in infants

Nov. 8, 1996

ImClone licenses NIH patent for stem cell and gene therapy

Nov. 8, 1996

Bacterial meningitis virtually eliminated in U.S. following introduction of Hib vaccine

Nov. 8, 1996

Novel DNA vaccine induces immune response to HSV-2

Nov. 1, 1996

StressGen's core technology receives patent protection

Nov. 1, 1996

Three-dimensional structure of the T-cell receptor determined

Nov. 1, 1996

Takeda discloses vaccine candidates

Nov. 1, 1996

AM-94 available for licensing

Oct. 25, 1996

AM-101 available for licensing

Oct. 25, 1996

Procept seeks partners for immunosuppression, AIDS, CD2 programs

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....